Zydus Lifesciences Limited — Omeprazole Exporter Profile
Indian Pharmaceutical Exporter · #8 for Omeprazole · $13.2M export value · DGFT Verified
Zydus Lifesciences Limited is the #8 Indian exporter of Omeprazole with $13.2M in export value and 313 verified shipments. Zydus Lifesciences Limited holds a 2.1% market share in Omeprazole exports across 18 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Omeprazole Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Omeprazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $9.7M | 326 | 52.4% |
| VIETNAM, DEMOCRATIC REP. OF | $1.6M | 61 | 8.6% |
| THAILAND | $1.5M | 71 | 8.1% |
| KENYA | $944.9K | 40 | 5.1% |
| SPAIN | $907.9K | 29 | 4.9% |
| YEMEN, DEMOCRATIC | $696.2K | 30 | 3.8% |
| VIETNAM | $454.5K | 15 | 2.5% |
| SUDAN | $370.4K | 13 | 2.0% |
| UGANDA | $335.2K | 15 | 1.8% |
| OMAN | $243.0K | 6 | 1.3% |
Zydus Lifesciences Limited exports Omeprazole to 27 countries. The largest destination is UNITED STATES accounting for 52.4% of Zydus Lifesciences Limited's Omeprazole shipments, followed by VIETNAM, DEMOCRATIC REP. OF (8.6%) and THAILAND (8.1%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Omeprazole from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $9.3M | 306 |
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $1.8M | 72 |
| AL-JABAL DRUGS AND MEDICAL APPLIANC | YEMEN, DEMOCRATIC | $884.2K | 37 |
| PHARMALAND (1982) CO. LTD | THAILAND | $809.8K | 50 |
| MAT CARGO | SPAIN | $747.3K | 19 |
| ABACUS PHARMA (AFRICA) LTD | UGANDA | $450.2K | 22 |
| PHARMALAND (1982) CO.LTD | THAILAND | $398.6K | 11 |
| ABACUS PHARMA AFRICA LTD | UGANDA | $373.3K | 10 |
| EVERSANA LIFE SCIENCE SERVICES, | UNITED STATES | $329.3K | 14 |
| HAPHARCO J.S.C. BRANCH. | VIETNAM | $251.5K | 7 |
Zydus Lifesciences Limited supplies Omeprazole to 53 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF) and AL-JABAL DRUGS AND MEDICAL APPLIANC (YEMEN, DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Omeprazole Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $248.0M worth of Omeprazole through 15,000 shipments from 975 suppliers to 179 countries, serving 2,858 buyers globally. Zydus Lifesciences Limited contributes $13.2M to this total, accounting for 2.1% of India's Omeprazole exports. Zydus Lifesciences Limited ships Omeprazole to 27 countries through 53 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Omeprazole Exports?
Zydus Lifesciences Limited's average Omeprazole shipment value is $42.1K per consignment, based on 313 shipments totaling $13.2M. The largest destination is UNITED STATES (52.4% of Zydus Lifesciences Limited's Omeprazole exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Omeprazole Exporters?
Zydus Lifesciences Limited ranks #8 among 975 Indian Omeprazole exporters with a 2.1% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($53.6M), CIPLA LIMITED ($44.0M), DR.REDDY'S LABORATORIES LTD ($35.7M). Zydus Lifesciences Limited processed 313 shipments to 18 destination countries.
What Omeprazole Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 | $1.8M | 52 |
| OCID 20MG CAPSULE (OMEPRAZOLE) 10X10 | $1.1M | 45 |
| OMEPRAZOLE DELAYED RELEASE CAPSULES USP | $583.5K | 16 |
| OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 DIST. NDC - 68382-500-10 MFG. NDC - 65841-761-10 (AS PER INVOICE. & P.LIST) | $493.3K | 10 |
| OMEPRAZOLE DR CAPS USP 40 MG 1 X 100 | $462.9K | 11 |
| OCID IV (INJECTION)(OMEPRAZOLE 40MG/VIAL& STERILISED WATER FOR INJ. BP (10ML)))(1 VIAL) | $352.6K | 31 |
| OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 (OTHER DETAILS AS PER INV & P.LIST)NOS | $310.3K | 9 |
| OCID 20MG CAPSULE- STRIP(OMEPRAZOLE)(10X10) | $283.2K | 16 |
| PHARMACEUTICAL MEDICINE FOR HUMAN USE -OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 | $263.2K | 7 |
| PHARMA : OMEPRAZOLE DR CAPSULES USP 40MG | $245.6K | 5 |
Zydus Lifesciences Limited exports 273 distinct Omeprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OMEPRAZOLE DR CAPS USP 40 MG 1 X 1000 with 52 shipments worth $1.8M.
Regulatory Requirements: Exporting Omeprazole to Key Markets
What Zydus Lifesciences Limited must comply with to export Omeprazole to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Lifesciences Limited Compare to Nearest Omeprazole Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | GLENMARK PHARMACEUTICALS LIMITED | $26.7M | 636 | 2 | $41.9K |
| 4 | MICRO LABS LIMITED | $17.2M | 344 | 23 | $50.0K |
| 8 | ZYDUS LIFESCIENCES LIMITED ★ | $13.2M | 313 | 18 | $42.1K |
| 7 | DR REDDYS LABORATORIES LIMITED | $11.7M | 234 | 10 | $50.0K |
| 10 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $7.9M | 205 | 3 | $38.4K |
Zydus Lifesciences Limited ranks #8 among 975 Indian Omeprazole exporters. Average shipment value of $42.1K compared to the market average of $254.4K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Omeprazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,900 | 12.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,316 | 8.8% |
| DELHI AIR CARGO ACC (INDEL4) | 857 | 5.7% |
| SAHAR AIR | 837 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 784 | 5.2% |
| HYDERABAD ICD (INSNF6) | 480 | 3.2% |
| Bombay Air | 463 | 3.1% |
| DELHI AIR | 456 | 3.0% |
What Other Gastrointestinal Products Does Zydus Lifesciences Limited Export?
Zydus Lifesciences Limited also exports these gastrointestinal products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Omeprazole Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Omeprazole, top products include Losartan, Carvedilol, Iron, Mesalamine, Potassium. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Omeprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Omeprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 709 individual customs records matching Zydus Lifesciences Limited exporting Omeprazole, covering 273 formulations to 27 countries via 53 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 179+ countries, 2,858+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Omeprazole Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Omeprazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Omeprazole Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Omeprazole. For current shipment-level data, contact TransData Nexus.